The Monocyte Subsets in Obese Patients With and Without Metabolic Syndrome
The Investigation of the Role of Inflammation in the Insulin Resistance Syndrome: The Monocyte Subsets in Obese Patients With and Without Metabolic Syndrome
Sponsor: University Hospital, Ioannina
Listed as NCT03241394, this observational or N/A phase trial focuses on Metabolic Syndrome and Obesity and remains ongoing. Sponsored by University Hospital, Ioannina, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Sep 2019 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Apr 2018 — Sep 2019 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Ioannina
For direct contact, visit the study record on ClinicalTrials.gov .